Study of JYP0015 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Clinical trial NCT06895031 · RECRUITING

Trial details

NCT number: NCT06895031
Sponsor: Guangzhou JOYO Pharma Co., Ltd
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Solid Tumor Pancreatic Ductal Adenocarcinoma (PDAC)Non-small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)

Start date: 2025-03-31
Primary completion: 2026-03-30
Enrollment: 210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.